Technology

RAPT Therapeutics

$19.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.28 (-6.23%) Today
$0.00 (0.00%) As of 12:00 PM UTC after-hours

Why Robinhood?

You can buy or sell RAPT and other stocks, options, and ETFs commission-free!

About RAPT

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA. The listed name for RAPT is RAPT Therapeutics, Inc. Common Stock.

CEO
Brian Russell Wong
Employees
67
Headquarters
South San Francisco, California
Founded
2015
Market Cap
497.34M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
188.65K
High Today
$20.37
Low Today
$19.09
Open Price
$20.22
Volume
233.74K
52 Week High
$51.21
52 Week Low
$10.52

Collections

RAPT Earnings

-$12.41
-$8.27
-$4.14
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 30, Pre-Market

You May Also Like

JD
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure